Recommendation comes after recent FDA approval and positive CHMP Opinion for ribociclib (Kisqali) to help reduce the risk of recurrence in EBC. (Image Credits: Pexels) The NCCN Clinical Practice ...

PACK EXPO International 2024 (Nov. 3–6; McCormick Place, Chicago), will showcase a wide array of innovations to help brand owners minimize energy consumption, waste, and carbon footprint and address ...

The Cincinnati Bengals saved one of their best looks for the Week 8 game against the Philadelphia Eagles. Then, the NFL flexed the showdown out of its planned spot. It’s not hard to see why, of course ...

Really a complete pack for a first time buyer , especially ... But the 1.2 litre engine and AMT gearbox combo could be better, the AMT feels bit jerky during shifts. Apart from that it is a ...

Novartis NVS announced that the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency (EMA) recommended granting approval to the breast cancer drug Kisqali ...

Tomarket's Secret Daily Combo has returned with engaging daily puzzles, where users can earn rewards by solving challenges. By following bot prompts on Telegram and interacting with specific items ...

With their high fibre content, the best oats combo pack can promote a feeling of fullness, reduce hunger and prevent overeating. They may also help stabilise blood sugar levels, preventing spikes ...

Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing authorization ...

EMA's CHMP issued a positive opinion for Novartis' Kisqali for high-risk early breast cancer. Kisqali showed a 25.1% reduced risk of cancer recurrence in Phase 3 NATALEE trial. The CHMP ...

Novartis said the European Medicines Agency has recommended its Kisqali cancer drug for market authorization. The drugmaker said Friday that the EMA's Committee for Medicinal Products for Human ...